Tolerability and Pharmacokinetics of CSPCHA115 Capsules in Chinese Healthy Volunteers

NCT04161547 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Asthma; Allergic Rhinitis

Interventions

DRUG: CSPCHA115 100 mg; Matching placebo 100 mg
DRUG: CSPCHA115 200 mg; Matching placebo 200 mg
DRUG: CSPCHA115 400 mg; Matching placebo 400 mg
DRUG: CSPCHA115 600 mg; Matching placebo 600 mg

Sponsor

CSPC ZhongQi Pharmaceutical Technology Co., Ltd.